Private Advisor Group’s Editas Medicine EDIT Stock Holding History

Private Advisor Group’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$30.7K	Buy	+11,954	New	+$35K	﹤0.01%	3079
2021 Q4	–	Sell	-6,296	Closed	-$259K	–	2167
2021 Q3	$259K	Sell	6,296 -5,187	-45%	-$284K	﹤0.01%	1767
2021 Q2	$650K	Sell	11,483 -970	-8%	-$35.8K	0.01%	1268
2021 Q1	$523K	Buy	12,453 +4,692	+60%	+$267K	0.01%	1276
2020 Q4	$545K	Buy	+7,761	New	+$319K	0.01%	1178
2020 Q3	–	Sell	-4,389	Closed	-$130K	–	2055
2020 Q2	$130K	Buy	+4,389	New	+$115K	﹤0.01%	1559

Other funds holding EDIT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Private Advisor Group's EDIT Position: Q3 2026 in Review

Private Advisor Group opened a new position in Editas Medicine (EDIT) in Q3 2026: 11,954 shares worth $30.7K. The stake represents ﹤0.01% of the portfolio and ranks #3079 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in EDIT as recently as Q3 2021.

Private Advisor Group first reported a position in EDIT in Q2 2020 and has held it in 6 quarters since. The position peaked at $650K in Q2 2021. 105 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

Private Advisor Group held 11,954 shares of Editas Medicine worth $30.7K as of Q3 2026.
Editas Medicine was a new Private Advisor Group position in Q3 2026.
Editas Medicine made up ﹤0.01% of Private Advisor Group's portfolio in Q3 2026, its #3079 holding.
Private Advisor Group first reported a position in Editas Medicine in Q2 2020 and has held it in 6 quarters since.
Private Advisor Group's Editas Medicine position peaked at $650K in Q2 2021.
105 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.